| Literature DB >> 18375358 |
Travis Kidner1, Menghua Dai, Prasad S Adusumilli, Yuman Fong.
Abstract
Hepatocellular cancer (HCC) is the fifth-leading cause of cancer and the third-leading cause of cancer related deaths world-wide. Current treatment options are limited, as HCC has been shown to be a highly resistant type of cancer to most current treatment modalities. Novel approaches are being explored in the fields of gene therapy, viral oncolytics, radioembolization, and several new biologic therapies. This article summarizes these recent clinical findings and discusses what role they will have in the future treatment of HCC.Entities:
Mesh：
Year: 2008 PMID： 18375358 PMCID： PMC3269813 DOI： 10.1016/j.soc.2008.01.002
Source DB: PubMed Journal: Surg Oncol Clin N Am ISSN： 1055-3207 Impact factor: 3.495